GE HEALTHCARE TECHNOLOGIES ($GEHC) posted quarterly earnings results on Wednesday, April 30th. The company reported earnings of $1.01 per share, beating estimates of $0.93 by $0.08. The company also reported revenue of $4,777,000,000, beating estimates of $4,759,309,973 by $17,690,027.
You can see Quiver Quantitative's $GEHC stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
GE HEALTHCARE TECHNOLOGIES Insider Trading Activity
GE HEALTHCARE TECHNOLOGIES insiders have traded $GEHC stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $GEHC stock by insiders over the last 6 months:
- ROLAND ROTT (CEO, Imaging) sold 3,577 shares for an estimated $309,338
- GEORGE A. NEWCOMB (Chief Accounting Officer) sold 2,000 shares for an estimated $185,080
- PHILIP RACKLIFFE (CEO, AVS) sold 900 shares for an estimated $78,867
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
GE HEALTHCARE TECHNOLOGIES Hedge Fund Activity
We have seen 620 institutional investors add shares of GE HEALTHCARE TECHNOLOGIES stock to their portfolio, and 550 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GENERAL ELECTRIC CO removed 13,281,302 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $1,038,332,190
- CITADEL ADVISORS LLC removed 3,058,206 shares (-86.2%) from their portfolio in Q4 2024, for an estimated $239,090,545
- CAPITAL RESEARCH GLOBAL INVESTORS added 2,608,066 shares (+4.5%) to their portfolio in Q4 2024, for an estimated $203,898,599
- VAN ECK ASSOCIATES CORP added 2,506,417 shares (+107.3%) to their portfolio in Q4 2024, for an estimated $195,951,681
- UBS GROUP AG added 2,415,990 shares (+156.6%) to their portfolio in Q4 2024, for an estimated $188,882,098
- HARRIS ASSOCIATES L P added 2,401,049 shares (+130.0%) to their portfolio in Q4 2024, for an estimated $187,714,010
- JANE STREET GROUP, LLC removed 2,333,786 shares (-92.4%) from their portfolio in Q4 2024, for an estimated $182,455,389
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
GE HEALTHCARE TECHNOLOGIES Congressional Stock Trading
Members of Congress have traded $GEHC stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $GEHC stock by members of Congress over the last 6 months:
- REPRESENTATIVE ROBERT BRESNAHAN has traded it 2 times. They made 1 purchase worth up to $15,000 on 02/25 and 1 sale worth up to $15,000 on 04/08.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
GE HEALTHCARE TECHNOLOGIES Analyst Ratings
Wall Street analysts have issued reports on $GEHC in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 04/14/2025
- Piper Sandler issued a "Overweight" rating on 11/15/2024
To track analyst ratings and price targets for GE HEALTHCARE TECHNOLOGIES, check out Quiver Quantitative's $GEHC forecast page.
GE HEALTHCARE TECHNOLOGIES Price Targets
Multiple analysts have issued price targets for $GEHC recently. We have seen 2 analysts offer price targets for $GEHC in the last 6 months, with a median target of $96.0.
Here are some recent targets:
- Ryan Zimmerman from BTIG set a target price of $95.0 on 04/14/2025
- Jason Bednar from Piper Sandler set a target price of $97.0 on 11/15/2024
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
